missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ DCAMKL2 Polyclonal Antibody
Description
Immunogen sequence: ENNMQAEVTG KLKQHFNNAL PKQNSTTTGV SVIMNTALDK EGQIFCSKHC QDSGRPGMEP ISPVPPSVEE IPVPGEAVPA PTPPESPTPH CPPAAPGGER AG Highest antigen sequence indentity to the following orthologs: Rat - 67%, Mouse - 74%.
DCAMKL2 is a serine/threonine kinase involved in signal transduction and cellular communication, and is the human homolog of a rat protein kinase expressed in cerebrocortical lamination that binds microtubules. The microtubule-polymerizing activity of the encoded protein is independent of its protein kinase activity. Mouse studies show that the DCX gene, another family member, and this gene share function in the establishment of hippocampal organization and that their absence results in a severe epileptic phenotype and lethality, as described in human patients with lissencephaly. Multiple alternatively spliced transcript variants have been identified.
Specifications
Specifications
| Antigen | DCAMKL2 |
| Applications | Immunohistochemistry (Paraffin) |
| Classification | Polyclonal |
| Concentration | 0.3 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 |
| Gene | DCLK2 |
| Gene Accession No. | Q8N568 |
| Gene Alias | 6330415M09Rik; AU044875; CaMK-like CREB regulatory kinase 2; CL2; CLICK2; Click-II; CLIK2; DCAMKL2; DCDC3; DCDC3B; DCK2; DCLK2; doublecortin and CaM kinase-like 2; doublecortin domain-containing protein 3B; doublecortin kinase 2; doublecortin like kinase 2; doublecortin-like and CAM kinase-like 2; Doublecortin-like kinase 2; RGD1308384; Serine/threonine-protein kinase DCLK2 |
| Gene Symbols | DCLK2 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?